Effects of High-Fat Diet on Cardiovascular Protein Expression in Mice Based on Proteomics.

cardiovascular disease high-fat diet lipid obesity proteomics

Journal

Diabetes, metabolic syndrome and obesity : targets and therapy
ISSN: 1178-7007
Titre abrégé: Diabetes Metab Syndr Obes
Pays: New Zealand
ID NLM: 101515585

Informations de publication

Date de publication:
2023
Historique:
received: 18 01 2023
accepted: 23 03 2023
medline: 5 4 2023
entrez: 4 4 2023
pubmed: 5 4 2023
Statut: epublish

Résumé

To investigate the effect of high-fat diet on protein expression in mouse heart and aorta using proteomic techniques. A high-fat diet was used to construct an obese mouse model, and body weight was checked regularly. After the experiment, serum lipid and oxidative stress levels were measured. Proteomic detection of cardiac and aortic protein expression. Cardiac and aortic common differentially expressed proteins (Co-DEPs) were screened based on proteomic results. Subsequently, functional enrichment analysis and screening of key proteins were performed. A high-fat diet significantly increased body weight in mice. Obese mice had considerably higher levels of TC, TG, LDL-C, ROS, and MDA. In the heart and aorta, 17 Co-DEPs were discovered. The results of functional analysis of these proteins indicated that they were mainly related to lipid metabolism. Ech1, Decr1, Hsd17b4, Hsdl2 and Acadvl were screened as key proteins. In mice, a high-fat diet causes lipid metabolism to become disrupted, resulting in higher levels of oxidative stress and lipid peroxidation products. Ech1, Decr1, Hsd17b4, Hsdl2 and Acadvl as cardiac and aortic Co-DEPs are closely related to lipid metabolism and may serve as potential diagnostic and therapeutic targets for obesity-induced cardiovascular disease.

Identifiants

pubmed: 37012931
doi: 10.2147/DMSO.S405327
pii: 405327
pmc: PMC10066704
doi:

Types de publication

Journal Article

Langues

eng

Pagination

873-882

Informations de copyright

© 2023 Pan et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

Onco Targets Ther. 2021 Jan 14;14:435-444
pubmed: 33488098
Front Physiol. 2021 Jun 28;12:653349
pubmed: 34262469
Nutrition. 2020 Oct;78:110942
pubmed: 32854019
Medicine (Baltimore). 2020 Jul 17;99(29):e21286
pubmed: 32702920
Eur Heart J. 2021 Sep 7;42(34):3404-3406
pubmed: 34379742
Circ Res. 2020 May 22;126(11):1477-1500
pubmed: 32437302
Int J Mol Sci. 2020 Apr 08;21(7):
pubmed: 32276429
Am J Physiol Endocrinol Metab. 2021 May 1;320(5):E925-E937
pubmed: 33813878
Am J Physiol Endocrinol Metab. 2020 Mar 1;318(3):E318-E329
pubmed: 31961704
Biochim Biophys Acta Mol Cell Biol Lipids. 2022 Mar;1867(3):159090
pubmed: 34896618
Biosci Rep. 2020 Apr 30;40(4):
pubmed: 32211805
Nat Rev Endocrinol. 2020 Feb;16(2):81-90
pubmed: 31836875
Clin Chim Acta. 2020 Apr;503:218-222
pubmed: 31794763
Mol Cell Biol. 2007 Sep;27(18):6361-71
pubmed: 17636013
Circ Res. 2021 Jan 8;128(1):136-149
pubmed: 33411633
Int J Mol Sci. 2019 May 22;20(10):
pubmed: 31121868
Aging (Albany NY). 2020 Jul 17;12(14):14699-14717
pubmed: 32678070
Nutr Metab (Lond). 2022 Oct 14;19(1):69
pubmed: 36242090
Circ Res. 2021 Apr 2;128(7):951-968
pubmed: 33793327
Elife. 2020 Jul 20;9:
pubmed: 32686647
Curr Pharm Des. 2013;19(32):5704-17
pubmed: 23448489
Biochem Biophys Res Commun. 2018 May 15;499(3):403-409
pubmed: 29526751
J Allergy Clin Immunol. 2005 May;115(5):911-9; quiz 920
pubmed: 15867843
Prev Med. 2016 Oct;91:62-69
pubmed: 27497658
J Endocrinol. 2018 Sep;238(3):R143-R159
pubmed: 29875164
Circ Res. 2020 Mar 13;126(6):789-806
pubmed: 32163341
Diabetes. 2004 Apr;53(4):1068-73
pubmed: 15047623
Biochim Biophys Acta. 2014 May;1842(5):677-85
pubmed: 24530811
Indian J Med Res. 2020 Jan;151(1):11-21
pubmed: 32134010
Antioxid Redox Signal. 2020 Mar 10;32(8):487-503
pubmed: 31830800
ARYA Atheroscler. 2020 Mar;16(2):94-101
pubmed: 33133208
Life Sci. 2016 Mar 1;148:183-93
pubmed: 26851532
PLoS One. 2017 Oct 10;12(10):e0186021
pubmed: 29016649
Biomed Pharmacother. 2013 Sep;67(7):557-60
pubmed: 23809371
Mol Cell Biochem. 2021 Nov;476(11):4019-4029
pubmed: 34216348
J Inflamm Res. 2022 Nov 24;15:6409-6425
pubmed: 36452054
Mol Cells. 2021 Apr 30;44(4):214-222
pubmed: 33935042
J Clin Endocrinol Metab. 2019 Dec 1;104(12):6118-6128
pubmed: 31219543
Front Endocrinol (Lausanne). 2021 Feb 24;12:568197
pubmed: 33716957
Sci Rep. 2019 Dec 2;9(1):18050
pubmed: 31792287

Auteurs

Xiaoyu Pan (X)

Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China.

Xueqing Zhang (X)

Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China.

Jiangli Ban (J)

Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China.

Lin Yue (L)

Department of Endocrinology, The Third Hospital of Shijiazhuang, Shijiazhuang, Hebei, People's Republic of China.

Lin Ren (L)

Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China.

Shuchun Chen (S)

Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China.

Classifications MeSH